InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Explore the detailed record of transactions filed by Goldan Keith A., Chief Financial Officer. Director active across 2 companies, notably OptiNose, Inc.. Cumulatively, 10 reports have been published. Total volume traded: €17k. The latest transaction was disclosed on 13 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations10 total
03,205 shares0
Common Stock
SEC:0001562180-22-005117:0·
€8,8814,617 shares@ €1.923552.5% of flow
Common Stock
SEC:0001494650-22-000029:0·
056,730 shares0
Common Stock
SEC:0001494650-22-000006·
056,730 shares0
Common Stock
SEC:0001494650-22-000006:0·
€842580 shares@ €1.452521.0% of flow
Common Stock
SEC:0001494650-21-000155·
€842580 shares@ €1.45255.0% of flow
Common Stock
SEC:0001494650-21-000155:0·
€1,370578 shares@ €2.370134.1% of flow
Common Stock
SEC:0001494650-21-000108·
€1,370578 shares@ €2.37018.1% of flow
Common Stock
SEC:0001494650-21-000108:0·
€1,803576 shares@ €3.130944.9% of flow
Common Stock
SEC:0001494650-21-000076·
€1,803576 shares@ €3.130910.7% of flow
Common Stock
SEC:0001494650-21-000076:0·
10 of 10 declarations
About Goldan Keith A.
Keith A. Goldan is the Chief Financial Officer of OptiNose, Inc. and Syndax Pharmaceuticals Inc. In this role, he is responsible for the financial management of both companies, including planning and financial reporting. His expertise in finance is crucial for the growth of these companies.
